No insider purchase over the last 90 days. The latest was filed 18 Feb 2026.
ADDvise Group AB (publ) is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. In the past year (18 October 2025 to 18 October 2026), 14 filings came from 5 insiders.
Purchases and sales both appear in the filings: 8 purchases (2 insiders, €2.4M) and 5 sales (5 insiders, €219k). Netting one side against the other leaves €2.2M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €1.3M, the purchase published on 30 January 2026 by Fredrik Celsing is the largest of the period. On the buying side, the filings list 1 board member and 1 finance chief among the declarants.
With 14 filings in twelve months, the company is more active than the median of 7 filings across the 885 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 18 purchases and 10 sales.
The last purchase on record was published on 18 February 2026, which is 242 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
+1 other insider
· cache
25 of 38 declarations
ADDvise Group AB (publ) is a Swedish company operating in the health and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).